BackAdma Biologics Overview

Adma Biologics Common Stock

Latest common stock for ADMA: $24K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$24000.00
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Adma Biologics Common Stock History

Loading

Adma Biologics vs. peers: Common Stock Comparison

Loading

Adma Biologics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Adma Biologics (ADMA) FAQ

As of the most recent data (September 2026), ADMA shows a common stock of $24K. That compares with $24K in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADMA's common stock is now $24K (was $24K) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Adma Biologics is outperforming or lagging.

Tracking ADMA's common stock over time shows whether Adma Biologics is scaling, shrinking, or reshaping that part of the business. The current reading is $24K That compares with $24K in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Adma Biologics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $24K) with ownership activity and broader fundamentals.

Adma Biologics's common stock is $24K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.